Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Transforming the prostatic tumor microenvironment with oncolytic virotherapy

Prostate cancer (PCa) was estimated to have the second highest global incidence rate for male non-skin tumors and is the fifth most deadly in men thus mandating the need for novel treatment options. MG1-Maraba is a potent and versatile oncolytic virus capable of lethally infecting a variety of prost...

Full description

Bibliographic Details
Main Authors: Matthew J. Atherton, Kyle B. Stephenson, Fanny Tzelepis, David Bakhshinyan, Jake K. Nikota, Hwan Hee Son, Anna Jirovec, Charles Lefebvre, Anna Dvorkin-Gheva, Ali A. Ashkar, Yonghong Wan, David F. Stojdl, Eric C. Belanger, Rodney H. Breau, John C. Bell, Fred Saad, Sheila K. Singh, Jean-Simone Diallo, Brian D. Lichty
Format: Article
Language:English
Published: Taylor & Francis Group 2018-07-01
Series:OncoImmunology
Subjects:
mg1-maraba
prostatic carcinoma
vaccination
tumor microenvironment
steap
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1445459

Similar Items

Similar Items